Clinical rationale for obtaining a precise diagnosis

Journal of Family Practice

Volumn 53, Issue SUPPL. 2, 2004, Pages

  Fromer, Leonard M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN E; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; OMALIZUMAB; ZAFIRLUKAST; IMMUNOGLOBULIN G;

AGE DISTRIBUTION; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ALLERGY; CLINICAL FEATURE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DRUG COST; EPIDEMIOLOGICAL DATA; FAMILY HISTORY; HUMAN; RADIOALLERGOSORBENT TEST; REVIEW; SKIN TEST; ALGORITHM; BLOOD; IMMUNOLOGICAL PROCEDURES; PREDICTION AND FORECASTING; RESPIRATORY TRACT ALLERGY; SENSITIVITY AND SPECIFICITY;

ALGORITHMS; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOLOGIC TESTS; PREDICTIVE VALUE OF TESTS; RESPIRATORY HYPERSENSITIVITY; SENSITIVITY AND SPECIFICITY; SKIN TESTS;

EID: 1842842066     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. American Academy of Allergy, Asthma, and Immunology. Task Force on Allergic Disorders. Executive Summary Report (1998). Available at: www.aaaai.org. Accessed January 20, 2004.
2. Cherry DK, Burt CW, Woodwell DA. National Ambulatory Medical Care Survey: 2001 Summary. Advanced data from Vital Health and Statistics; No. 337. Hyattsville, Md: National Center for Health Statistics; 2002.
3. American Academy of Allergy, Asthma, and Immunology. The Allergy Report, 2000. Milwaukee, Wis: AAAAI; 2000. Available at: www.theallergyreport.com. Accessed on January 20, 2004.
4. Sigurs N, Hattevig G, Kjellman B, et al. Appearance of atopic disease in relation to serum IgE antibodies in children followed up from birth for 4 to 15 years. J Allergy Clin Immunol. 1994;94:757-763.
5. Sasai K, Furukawa S, Muto T, et al. Early detection of specific IgE antibody against house dust mite in children at risk of allergic disease. J Paediatr. 1996;128:834-840.
6. Kulig M, Bergmann R, Tacke U, et al. Long-lasting sensitization to food during the first two years precedes allergic airway disease. Pediatr Allergy Immunol. 1998;9:61-67.
7. Ahlstedt S. Mediators in allergy diagnosis. Allergy Clin Immunol Int. 1998;10:37-44.
8. Boner AL, Niero E, Antolini I, Valletta EA, Gaburro D. Pulmonary function and bronchial reactivity in asthmatic children with house dust-mite allergy during prolonged stay in the Italian Alps (Misurina, 1756 m). Ann Allergy. 1985;54:42-45.
9. Boner AL, Peroni DG, Piacentini GL, Venge P. Influence of allergen avoidance at high altitude on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy. 1993;23:1021-1026.
10. Szeinbach S, Boye M, Muntendam P, O'Connor R. Diagnostic assessment and resource utilization in patients prescribed non-sedating antihistamines. Paper presented at: Annual Meeting of American In Vitro Allergy and Immunology Society; October 16, 2000.
11. Williams PB, Ahlstedt S, Barnes JH, et al. Are our impressions of allergy test performances correct? Ann Allergy Asthma Immunol. 2003;91:26-33.
12. Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 54. Management of Allergic and Nonallergic Rhinitis. Available at: www.ahrq.gov. Accessed on February 6, 2004.
13. Dykewicz MS, Fineman S. Executive summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol. 1998;81:463-468.
14. Crobach MJ, Hermans J, Kaptein AA, Ridderikhoff J, Petri H, Mulder JD. The diagnosis of allergic rhinitis: how to combine the medical history with the results of radioallergosorbent tests and skin prick tests. Scand J Prim Care. 1998;16:30-36.
15. Selner JC, Sullivan TJ, Ahlstedt S, et al. Current issues relating to in vitro testing for allergen-specific IgE: a workshop report. Ann Allergy Asthma Immunol. 1999;82:407-412.
16. Gelfand EW, Plaut M, Washington T, et al for the National Institute of Allergy and Infectious Diseases. Current trends in allergic reactions: a multidisciplinary approach to patient management. Clinician. 2003;21(3)):1-23. Available at: www.niaid.nih.gov/research/dait.htm. Accessed on March 15, 2004.
17. National Asthma Education and Prevention Program. NAEPP Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma: Update on Selected Topics 2002. NIH publication 97-4051. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 2002. Available at: www.nhlbi.nih.gov/guidelines/asthma/asthupdt.htm. Accessed on January 20, 2004.
18. Pharmacia CAP System Specific IgE FEIA. Directions for Use. Uppsala, Sweden: Pharmacia AB Diagnostics Div.; February 2002.
19. Wood RA, Phipatanakul W, Hamilton WG, Eggleston PA. A comparison of skin prick tests, intradermal skin tests, and RAST in the diagnosis of cat allergy. J Allergy Clin Immunol. 1999;103:773-779.
20. Poon AW, Goodman CS, Rubin FJ. In vitro and skin testing for allergy: comparable clinical utility and costs. Am J Managed Care. 1998;4:969-985.
21. Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med. 2004;140:278-289.
22. Williams PB, Barnes JH, Szeinbach SL, Sullivan TJ. Analytic precision and accuracy of commercial immunoassays for specific IgE: establishing a standard. J Allergy Clin Immunol. 2000;105:1221-1230.
23. Hamilton RG. Responsibility for quality IgE antibody results rests ultimately with the referring physician (editorial). Ann Allergy Asthma Immunol. 2001;86:353-354.
24. Nishioka K, Yasueda H, Saito H. Preventive effect of bedding encasement with microfine fibers on mite sensitization. J Allergy Clin Immunol. 1998;101:28-32.
25. Halken S, Host A, Niklassen U, et al. Effect of mattress and pillow encasings on children with asthma and house dust-mite allergy. J Allergy Clin Immunol. 2003;111:169-176.
26. Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA. 1998;279:1181-1186.
27. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med. 1998;158:1213-1220.
28. Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol. 2001;108:184-190.
29. Walker S, Monteil M, Phelan K, Lasserson TJ, Walters, EH. Anti-IgE for chronic asthma. Cochrane Database Syst Rev. 2003;(3):CD003559.
30. Joint Task Force on Practice Parameters. Allergen immunotherapy: a practice parameter. Ann Allergy Asthma Immunol. 2003;90(suppl 1):1-40.
31. Berger WE, Fineman SM, Lieberman P, Miles RM for the Rhinitis Study Group. Double-blind trials of azelastine nasal spray monotherapy versus combined therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1999;82:535-541.
32. Host A, Andrae S, Charkin S, et al. Allergy testing in children: why, who, when and how? Statement of The Section on Pediatrics, European Academy of Allergy and Immunology. Allergy. 2003;58:1-11.
33. Hedges HH, Pollart SM. Allergic or nonallergic rhinitis? Taking the questions out of diagnosis and treatment. Available at: www.aafp.org/x24675.xml. Accessed on January 20, 2004.
34. Williams PB, Dolen WK, Koepke JW, Selner JC. Comparison of skin testing and three in vitro assays for specific IgE in the clinical evaluation of immediate hypersensitivity. Ann Allergy. 1992;68:35-45.